Factual investigation of Portoplumonary hypertension in chronic liver disease

Factual investigation of Portoplumonary hypertension in chronic liver disease - Factual investigation of Portoplumonary hypertension in chronic liver disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042287

Enrollment

2500

Registered

2020-10-29

Start date

2020-10-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease, Portoplumonary hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients over 20 years of age who have been diagnosed with chronic liver disease in our hospital and present with clinical symptoms (e.g., chest pain, dyspnea, syncope, blood sputum, etc.) that are suspicious of PoPH. (2) Patients diagnosed with portal hypertension who can be followed up in our hospital.

Exclusion criteria

Exclusion criteria: (1)Cases for which follow-up was not possible at our hospital (2) Any other cases that the researcher deems inappropriate.

Design outcomes

Primary

Measure	Time frame
the prevalence of PoPH in Japanese patients with chronic liver disease	—

Secondary

Measure	Time frame
the etiology of PoPH in Japanese patients with chronic liver disease the overall 5-year survival rate	—

Countries

Japan

Contacts

Public ContactShunichi Wakabayashi

Shinshu university Department of Internal Medicine, Division of Gastroenterology

ninai@shinshu-u.ac.jp0263-37-2634

Outcome results